LEARN ABOUT
OUR PIPELINE
Advancing next-generation anti-platelet therapy.
Targeting GPVI
| EMA601 | Stroke, Myocardial Infarction |
| (EMF-002) | |
Discover
Preclinical
Phase I
Phase II
Phase III
Other Programs
| EMF-004 | Thrombocytopenia / Bleeding |
| EMF-006 | Autoimmune Disorders |
Discover
Preclinical
Phase I
Phase II
Phase III
Discover
Preclinical
Phase I
Phase II
Phase III
CONNECT
Get in touch
-
EMFRET Analytics GmbH & Co. KG
Am Morgenroth 6
97246 Eibelstadt
Germany - service@emfret.com